BioCardia (BCDA) News Today → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free BCDA Stock Alerts $0.38 +0.01 (+2.15%) (As of 02:14 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohortglobenewswire.com - April 25 at 9:00 AMBioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 1 at 3:53 PMBioCardia, Inc.: BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Resultsfinanznachrichten.de - March 29 at 5:54 PMBioCardia Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - March 29 at 7:53 AMPreview: BioCardia's Earningsbenzinga.com - March 28 at 4:52 PMBioCardia is about to announce its earnings — here's what to expectmarkets.businessinsider.com - March 28 at 2:02 PMQ4 2023 BioCardia Inc Earnings Callfinance.yahoo.com - March 28 at 2:02 PMBioCardia: Q4 Earnings Insightsbenzinga.com - March 27 at 5:19 PMBioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Resultsglobenewswire.com - March 27 at 4:00 PMBioCardia Inc.money.usnews.com - March 20 at 4:42 PMBioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024globenewswire.com - March 20 at 7:00 AMBioCardia, Inc.: BioCardia and StemCardia Announce Biotherapeutic Delivery Partnershipfinanznachrichten.de - March 13 at 8:40 AMBioCardia and StemCardia Announce Biotherapeutic Delivery Partnershipglobenewswire.com - March 13 at 7:00 AMBioCardia, Inc.: BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Studyfinanznachrichten.de - March 12 at 10:30 AMBioCardia spikes after Medicare coverage for cell therapy trialmsn.com - March 12 at 10:07 AMBioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Studyglobenewswire.com - March 12 at 7:00 AMBioCardia Reports Positive Interim Results From Phase III CardiAMP Cell Therapy Heart Failure Trialmarkets.businessinsider.com - March 4 at 1:14 PMBioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failureglobenewswire.com - March 4 at 8:00 AMBCDA Mar 2024 1.500 callfinance.yahoo.com - February 27 at 6:07 PMBCDA Aug 2024 0.500 callfinance.yahoo.com - February 17 at 1:39 AMBCDA Mar 2024 0.500 callfinance.yahoo.com - February 17 at 1:39 AMBioCardia Inc Secures Funding Through Private Placementmsn.com - February 10 at 8:12 AMBioCardia Inc Conducts Unregistered Equity Securities Salemsn.com - February 10 at 8:12 AMBioCardia Launches Pivotal CardiAMP HF II Trialmsn.com - February 9 at 8:56 AMBioCardia, Inc.: BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDAfinanznachrichten.de - February 8 at 8:37 AMBioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDAfinance.yahoo.com - February 8 at 8:37 AMBioCardia to Present CardiAMP and CardiALLO at Conferencemsn.com - February 1 at 7:42 AMBioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conferencefinance.yahoo.com - January 31 at 9:30 AMBioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholdersfinance.yahoo.com - January 3 at 8:29 AMPositive Signs As Multiple Insiders Buy BioCardia Stockfinance.yahoo.com - January 1 at 6:07 PMBioCardia Stock (NASDAQ:BCDA) Dividends: History, Yield and Datesbenzinga.com - December 22 at 12:24 AMBioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection Fractionfinance.yahoo.com - December 19 at 7:57 AMBioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutesfinance.yahoo.com - December 18 at 8:38 AMBioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approvalfinance.yahoo.com - November 29 at 9:00 AMBioCardia Announces $1.3 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rulesfinance.yahoo.com - November 16 at 3:00 PMBioCardia (BCDA) Soars 168% on FDA Nod to Heart Failure Studymsn.com - November 15 at 12:29 PMCrude Oil Moves Higher; Beauty Health Shares Plungemsn.com - November 14 at 3:18 PM200% Gain In One Day - Why Is Heart Failure Focused BioCardia Stock Soaring Today?msn.com - November 14 at 3:18 PMNasdaq Surges 2%; US Inflation Rate Slows In Octoberbenzinga.com - November 14 at 10:18 AMmarketbeat.com - November 14 at 9:44 AMBioCardia: FDA Approves CardiAMP Heart Failure II Protocol For Autologous Cell Therapymarkets.businessinsider.com - November 14 at 9:42 AMBioCardia Shares Double After FDA Approves CardiAMP Trialmarketwatch.com - November 14 at 9:42 AMBioCardia stock jumps premarket as FDA approves heart failure trialmsn.com - November 14 at 9:42 AMmarketbeat.com - November 14 at 9:39 AMBioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failurefinance.yahoo.com - November 14 at 7:39 AMBioCardia Inc BCDAmorningstar.com - November 12 at 8:45 AMBioCardia’s Strategic Clinical Advancements and Potential Growth Opportunities Prompt Buy Ratingmarkets.businessinsider.com - November 10 at 8:20 AMBioCardia, Inc. (NASDAQ:BCDA) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 9 at 3:02 PMBioCardia Inc (BCDA) Reports Q3 2023 Financial Results and Business Updatesfinance.yahoo.com - November 8 at 6:34 PMBioCardia Reports Third Quarter 2023 Business Highlights and Financial Resultsfinance.yahoo.com - November 8 at 5:30 PM Get BioCardia News Delivered to You Automatically Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. BCDA Media Mentions By Week BCDA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCDA News Sentiment▼0.670.33▲Average Medical News Sentiment BCDA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCDA Articles This Week▼31▲BCDA Articles Average Week Get BioCardia News Delivered to You Automatically Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ONVO News IKT News GENE News SRNE News COEP News TTNP News CELZ News SNTI News FRTX News PALI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCDA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
